Thursday, October 8, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· January 22, 2026

AI-Driven Drones Enter the Quantum Era, Unlocking a New High-Growth Defense and Commercial Market

View original at globenewswire.com
AI-Driven Drones Enter the Quantum Era, Unlocking a New High-Growth Defense and Commercial Market NEW YORK, Jan…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Katie has spent her entire career as a passionate advocate to ensure the United States maintains its technological edge—from strengthening the industrial base to protecting critical systems and capabilities across the Department of War. Her passion for defending the nation and advancing the kind of breakthrough innovation that quantum computing represents will help accelerate IonQ's growth and impact

    80% confidence
  • Our open and modular architecture enables the hands-on R&D and innovation C-DAC requires to bring hybrid classical-quantum supercomputing to their community of scientific and industrial partners. This highlights the growing demand for on-premises quantum computers as national governments prioritize quantum computing, and Rigetti's leadership in delivering state-of-the-art quantum computing systems for the world's leading researchers

    80% confidence
  • Quantum computing market is projected to reach USD 20.20 billion by 2030 from USD 3.52 billion in 2025, at a CAGR of 41.8% during the forecast period

    80% confidence
  • We are honored that C-DAC has recognized the value of Rigetti's quantum computing technology and expertise by selecting our system for the first quantum computer to be installed and integrated into their supercomputing data center and systems

    80% confidence
  • We are building a technology platform to strengthen autonomous operations in contested environments, enhancing security and resilience, as well as to position ZenaTech for larger, long-term defense opportunities that align with global defense priorities

    80% confidence
  • The broader quantum computing market is expected to grow from $3.52 billion in 2025 to over $20 billion by 2030, with specialized applications in aerospace and defense, such as drone operations, representing a significant growth driver

    80% confidence
  • Quantum computing is one of the most consequential technologies shaping the future of national defense, economic competitiveness, and global security

    80% confidence
  • Creating our own quantum computer prototype is an important foundational step in having a vertically integrated platform designed to handle the massive volumes of data generated by our drone systems and to support mission-critical intelligence capabilities that modern defense forces demand

    80% confidence
  • ZenaTech currently expects to have the five qubit quantum prototype complete and be operational later in 2026

    80% confidence
  • D-Wave expects the acquisition to significantly accelerate the time to a scaled, error-corrected gate-model quantum computer alongside and complementary to its commercial annealing quantum computing systems

    80% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Autumn 2026 Biopharma Catalyst Season: Late-Breaking Data, FDA Milestones and the Rise of AI-Designed Drugs
Late-September and early-October 2026 conferences (EASD, EADV, IGCS) brought a cluster of positive late-breaking trial readouts. These covered obesity and metabolic disease (Novo Nordisk's CagriSema), immunology (Lilly's EBGLYSS, tulisokibart) and oncology (Rina-S, Agenus BOT+BAL). Ahead lie hard regulatory catalysts, led by the 14 Nov 2026 FDA PDUFA date for ivonescimab. At the same time, Insilico-style AI-designed drugs such as rentosertib are showing anti-aging signals. That points to AI-driven drug discovery moving from concept toward clinical validation. Unrelated tech and regulatory items (Tesla Cybercab probe, xAI litigation, OpenAI agent incident) and the speculative QAIAx claims are peripheral to this story.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,362 source documents archived
Query this data → isubstrate.com
AI-Driven Drones Enter the Quantum Era, Unlocking a New High-Growth Defense and Commercial Market — Source | Via News | ViaNews Market